Huang et al. (2013) evaluated the effects of bevacizumab on the formation of fibrosis and also described that this antibody could alleviate liver fibrosis by blocking the effect of VEGF on hepatic stellate cells [25]. This evidence concerns the gene VEGFA and Hepatic fibrosis.